Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected …
$2.76-0.72%
报价 2026-11-09
市值
$14.9M
EV
$1.8M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -49.6%
$2.76$5.48
筛选结果
pipeline · 2026-11-09Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Medical - Pharmaceuticals| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| NEUPNeuphoria Therapeutics Inc. | $14.9M | -0.7% | – | 104.8% | – | – | 0.4x | |
| FRMMETHZilla Corporation | $38M | -5.3% | +10.2% | 82.3% | – | – | – | |
| PETSPetMed Express, Inc. | $27.1M | +2.5% | +1.0% | 27.6% | – | – | – | |
| YI111, Inc. | $25.8M | +0.5% | – | 5.7% | – | – | – | |
| CIRCAtlantic International Corp | $18.4M | +6.3% | – | 8.6% | – | – | – | |
| KYNBKyntra Bio, Inc. | $15.8M | +4.6% | +16.2% | 75.8% | 0.2x | – | – | |
| POMPOMDOCTOR Ltd | $13.3M | -14.4% | – | 11.7% | – | – | – | |
| AZRAzora Therapeutics, Inc. | $10.2M | -3.0% | – | – | – | – | – | |
| RKTOHoth Therapeutics, Inc. | $8.8M | -1.4% | – | 0% | – | – | – | |
| 同行中位数 | – | – | +10.2% | 11.7% | 0.2x | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。
研究材料
电话会纪要摘要
暂无纪要摘要。